α-Syn overexpression, NRF2 suppression, and enhanced ferroptosis create a vicious cycle of neuronal loss in Parkinson's disease.


Journal

Free radical biology & medicine
ISSN: 1873-4596
Titre abrégé: Free Radic Biol Med
Pays: United States
ID NLM: 8709159

Informations de publication

Date de publication:
01 11 2022
Historique:
received: 01 07 2022
revised: 08 09 2022
accepted: 16 09 2022
pubmed: 24 9 2022
medline: 19 10 2022
entrez: 23 9 2022
Statut: ppublish

Résumé

Parkinson's disease (PD) is the second most common neurodegenerative disorder, affecting millions each year. Most PD cases (∼90%) are sporadic, resulting from the age-dependent accumulation of pathogenic effects. One key pathological hallmark of PD progression is the accumulation of alpha-synuclein (α-syn), which has been shown to negatively affect neuronal function and viability. Here, using 3- and 6-month-old Nrf2

Identifiants

pubmed: 36150560
pii: S0891-5849(22)00597-4
doi: 10.1016/j.freeradbiomed.2022.09.015
pmc: PMC9841923
mid: NIHMS1855793
pii:
doi:

Substances chimiques

NF-E2-Related Factor 2 0
NFE2L2 protein, human 0
Nfe2l2 protein, mouse 0
alpha-Synuclein 0

Types de publication

Journal Article Review Research Support, Non-U.S. Gov't Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

130-140

Subventions

Organisme : NIEHS NIH HHS
ID : P42 ES004940
Pays : United States
Organisme : NIEHS NIH HHS
ID : R35 ES031575
Pays : United States

Informations de copyright

Copyright © 2022 Elsevier Inc. All rights reserved.

Références

Free Radic Biol Med. 2019 Mar;133:221-233
pubmed: 30266679
Neurotherapeutics. 2012 Apr;9(2):297-314
pubmed: 22350713
NPJ Parkinsons Dis. 2020 Jul 9;6:15
pubmed: 32665974
Redox Biol. 2021 May;41:101896
pubmed: 33799121
J Neurosci Res. 2011 Jul;89(7):1091-102
pubmed: 21488084
JCI Insight. 2017 Apr 6;2(7):e90777
pubmed: 28405617
J Neurosci Res. 2002 Jun 1;68(5):568-78
pubmed: 12111846
Cell Death Differ. 2020 Oct;27(10):2781-2796
pubmed: 32341450
Free Radic Biol Med. 2008 Aug 1;45(3):242-55
pubmed: 18456002
Annu Rev Pharmacol Toxicol. 2022 Jan 6;62:255-277
pubmed: 34637322
Aging Dis. 2021 Jul 1;12(4):964-982
pubmed: 34221542
Redox Biol. 2019 May;23:101107
pubmed: 30692038
Cell. 2012 May 25;149(5):1060-72
pubmed: 22632970
J Alzheimers Dis. 2018;66(2):453-460
pubmed: 30320583
Front Mol Neurosci. 2019 Dec 05;12:299
pubmed: 31866823
Aging Cell. 2019 Dec;18(6):e13031
pubmed: 31432604
Annu Rev Pharmacol Toxicol. 2019 Jan 6;59:555-575
pubmed: 30256716
Curr Protoc Neurosci. 2010 Oct;Chapter 4:Unit 4.21
pubmed: 20938923
Med Res Rev. 2021 Mar;41(2):770-784
pubmed: 32656815
Antioxid Redox Signal. 2016 Mar 1;24(7):376-91
pubmed: 26564470
J Neurosci. 2004 Oct 20;24(42):9434-40
pubmed: 15496679
Regen Med. 2015;10(5):563-77
pubmed: 26237701
Mol Neurodegener. 2019 Jul 22;14(1):29
pubmed: 31331359
Proc Natl Acad Sci U S A. 2004 Mar 9;101(10):3381-6
pubmed: 14985508

Auteurs

Anandhan A (A)

Department of Pharmacology and Toxicology, University of Arizona, Tucson, AZ, USA.

Chen W (C)

Department of Pharmacology and Toxicology, University of Arizona, Tucson, AZ, USA.

Nguyen N (N)

Department of Neurology, University of Arizona, Tucson, AZ, USA.

Madhavan L (M)

Department of Neurology, University of Arizona, Tucson, AZ, USA; Evelyn F McKnight Brain Institute and Bio5 Institute, University of Arizona, Tucson, AZ, USA.

Dodson M (D)

Department of Pharmacology and Toxicology, University of Arizona, Tucson, AZ, USA. Electronic address: dodson@pharmacy.arizona.edu.

D D Zhang (DD)

Department of Pharmacology and Toxicology, University of Arizona, Tucson, AZ, USA; Arizona Cancer Center, University of Arizona, Tucson, AZ, 85724, USA. Electronic address: dzhang@pharmacy.arizona.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH